Company Filing History:
Years Active: 2013-2016
Title: Venkata Ramachandra Rao Vasamsetty: Innovator in Recombinant DNA Therapeutics
Introduction
Venkata Ramachandra Rao Vasamsetty is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of recombinant DNA therapeutics, particularly in the development of methods for producing functional human insulin proteins. With a total of 3 patents to his name, his work has the potential to impact the medical and pharmaceutical industries.
Latest Patents
One of his latest patents is titled "Method of downstream processing for conversion of human insulin precursor molecule into a functional human insulin protein molecule." This patent outlines methods that involve bioinformatics design and the synthesis of artificial genes for a human insulin precursor. The process includes cloning these artificial genes into an expression vector and expressing them in suitable organisms. Additionally, the patent details downstream processing techniques for obtaining protein precursor molecules and converting them into functional proteins.
Another significant patent is "Polynucleotide and polypeptide sequence and methods thereof." Similar to his previous work, this patent also focuses on recombinant DNA therapeutics. It emphasizes the design and synthesis of artificial genes, cloning, and expression in organisms, along with downstream processing for functional protein production.
Career Highlights
Venkata Ramachandra Rao Vasamsetty is currently employed at Bigtec Private Limited, where he continues to innovate in the field of biotechnology. His expertise in recombinant DNA technology has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
He collaborates with talented individuals such as Mulakkapurath Narayanan Manoj and Madhuri Baliga, contributing to a dynamic work environment that fosters innovation and creativity.
Conclusion
Venkata Ramachandra Rao Vasamsetty is a pioneering inventor whose work in recombinant DNA therapeutics is paving the way for advancements in medical science. His patents reflect a commitment to improving healthcare through innovative solutions.